Syringes Market Report

The syringe industry is witnessing substantial growth, driven by various factors that have a global impact. One of the primary drivers is the increasing vaccination administration rates around the world. Governments and healthcare organizations across the globe are focusing on vaccination campaigns to combat various infectious diseases, leading to a rising demand for syringes for vaccine delivery. The expansion of the healthcare industry is also playing a significant role in the growth of the syringes market. As healthcare infrastructure improves and access to medical services increases, there is a corresponding increase in the demand for medical devices, including syringes, to support various medical procedures and treatments. 

As a result, the worldwide expansion of the healthcare industry, changing attitudes towards vaccines, improvements in the syringes technologies market, increased popularity of cyclic olefin polymers (COP) polymer syringes, and the growing need to reduce the mortality rate of some lethal diseases are all expected to drive syringe demand in the coming years.  Another factor contributing to the growth of the syringe industry is the growing popularity of disposable syringes. Disposable syringes offer advantages in terms of infection control, ease of use, and reduced risk of contamination, making them a preferred choice for medical practitioners and patients alike.

Major market players are focusing on research and development in order to develop innovative products that enhance their product portfolio. They are also implementing various market strategies such as new product launches, mergers, and acquisitions in order to strengthen their foothold in the market. In October 2022, Terumo Pharmaceutical Solutions, a branch of Terumo Corporation and a major manufacturer of primary container, injectable, and infusion treatment devices, introduced a ready-to-fill polymer syringe for difficult biotech drugs with higher capacity. The PLAJEXTM 2.25 mL with Tapered Needle is particularly intended for the Biotech industry, making it ideal for difficult drug applications such as high-viscosity biotech drugs. 

Again, Becton, Dickinson,n and Company, a global medical technology company, introduced a next-generation glass pre-fillable syringe (PFS) in September 2022, establishing a new performance benchmark for vaccine PFS with new and strengthened criteria for processability, cosmetics, contamination, and integrity. In order to meet the complex and growing demands of vaccine manufacture, the new BD EffivaxTM Glass Pre-fillable Syringe was created in partnership with major pharmaceutical companies. Later, in June 2023, Endo International plc stated that its Par Sterile Products division had begun selling PREVDUOTM (neostigmine methylsulfate and glycopyrrolate injection) pre-filled syringes, the first and only FDA-approved neostigmine-glycopyrrolate combination product in the United States.

While the syringe market has seen significant growth and advancement over the years, it also faces several limitations and challenges. For example, the risk of needlestick injuries is a major concern for healthcare professionals and patients alike. Accidental needlestick injuries can lead to the transmission of bloodborne infections, such as HIV, hepatitis B, and hepatitis C. Despite the introduction of safety-engineered syringes, compliance with their use and proper disposal remains a challenge, leading to continued incidents of needlestick injuries.

In addition, the development and adoption of needleless drug delivery systems, such as inhalers, transdermal patches, and needle-free injectors, pose competition to traditional syringes. These alternatives offer less invasive and painless drug delivery, which can impact the demand for conventional syringes. Moreover, the extensive use of disposable syringes contributes to plastic waste generation, which can have environmental consequences. Efforts to promote eco-friendly and biodegradable materials for syringe production are emerging, but adoption rates are still relatively low.

Medtronic Plc., Becton, Dickinson, and Company, Terumo Corporation, Gerresheimer AG, Hindustan Syringes & Medical Devices Limited, B. Braun Melsungen AG, Nipro Corporation, Schott AG, Smith's Group Plc., Codan Medizinische Geräte GmbH & Co Kg. are some of the prominent market players operating in the global syringes market.

The Asia-Pacific region offers promising opportunities for key players in the syringes market due to various factors. These factors include the increasing demand for syringes, the growth of the R&D sector, healthcare reforms, and advancements in syringe technology. Additionally, the region benefits from a rising demand for advanced medical facilities and an increase in the number of people suffering from chronic diseases in emerging economies. These factors all contribute to the expansion of the syringe market in the region. Furthermore, leading syringe manufacturers are strategically focusing on expanding their presence in emerging Asian-Pacific countries to tap into the potential for high market share. This expansion initiative is expected to drive the market's growth in the region. 

On the other hand, North America is anticipated to experience significant growth in the syringes market owing to the advanced healthcare infrastructures, the presence of prominent global competitors, and investments in the R&D sector. Furthermore, the growth is also influenced by increasing usage of self-administration due to the rise in chronic conditions. Besides, government assistance in the form of financial aid to market participants in their manufacturing units will create a number of chances for the syringe market to expand.